Another approach exploited to inhibit NOTCH1 activity is inhibition of the sarco/endoplasmic reticulum calcium ATPase using apsigargin.103,104 Potential combinations of those new anti-NOTCH therapies with GCs might benefit GC-resistant T-ALL patients. The gene discussed is NOTCH1; the disease is acute lymphoblastic leukemia.